KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Gross Margin (2020 - 2025)

Clover Health Investments' Gross Margin history spans 6 years, with the latest figure at 15.22% for Q4 2025.

  • For Q4 2025, Gross Margin fell 1669.0% year-over-year to 15.22%; the TTM value through Dec 2025 reached 18.26%, down 912.0%, while the annual FY2025 figure was 18.5%, 811.0% down from the prior year.
  • Gross Margin reached 15.22% in Q4 2025 per CLOV's latest filing, up from 14.73% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 679.81% in Q4 2022 to a low of 213.48% in Q3 2022.
  • Average Gross Margin over 5 years is 39.7%, with a median of 21.58% recorded in 2025.
  • Peak YoY movement for Gross Margin: soared 79965bps in 2022, then crashed -66221bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 119.84% in 2021, then surged by 667bps to 679.81% in 2022, then tumbled by -97bps to 17.59% in 2023, then soared by 81bps to 31.91% in 2024, then tumbled by -52bps to 15.22% in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Gross Margin are 15.22% (Q4 2025), 14.73% (Q3 2025), and 20.86% (Q2 2025).